MD291Y - Method for predicting the development of adverse effects in hearing aids - Google Patents
Method for predicting the development of adverse effects in hearing aids Download PDFInfo
- Publication number
- MD291Y MD291Y MDS20100154A MDS20100154A MD291Y MD 291 Y MD291 Y MD 291Y MD S20100154 A MDS20100154 A MD S20100154A MD S20100154 A MDS20100154 A MD S20100154A MD 291 Y MD291 Y MD 291Y
- Authority
- MD
- Moldova
- Prior art keywords
- adverse effects
- predicting
- occurrence
- development
- hearing aids
- Prior art date
Links
- 230000002411 adverse Effects 0.000 title abstract 4
- 230000000694 effects Effects 0.000 title abstract 4
- 206010011878 Deafness Diseases 0.000 abstract 1
- 231100000895 deafness Toxicity 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 230000006870 function Effects 0.000 abstract 1
- 208000016354 hearing loss disease Diseases 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
Landscapes
- Prostheses (AREA)
- Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
Abstract
Inventia se refera la medicina, in special la otorinolaringologie. Esenta inventiei consta in aceea ca metoda de pronostic al aparitiei efectelor adverse la protezarea auditiva include examenul clinic si paraclinic ce releva urmatorii parametri: varsta pacientului (VP), infectiile suportate (FS), evolutia surditatii (ES), pragul auditiv in limitele 0...120 dB (PA), indicele de articulare (IA), apoi se calculeaza functia discriminanta (F) conform formulei:F = -7.927 + 0.144 · VP – 0.476 · FS – 0.975 · ES + 0.073 · PA + 0.065 · IA,si in cazul in care F>0 se prognozeaza lipsa riscului de aparitie a efectelor adverse, iar cand F<0 - riscul aparitiei efectelor adverse.The invention relates to medicine, in particular to otolaryngology. The essence of the invention is that the method for predicting the occurrence of adverse effects on the hearing prosthesis includes the clinical and paraclinical examination that reveals the following parameters: age of the patient (VP), infections supported (FS), evolution of deafness (ES), hearing threshold within limits 0. ..120 dB (PA), the joint index (IA), then calculate the discriminating function (F) according to the formula: F = -7.927 + 0.144 · VP - 0.476 · FS - 0.975 · ES + 0.073 · PA + 0.065 · IA , and if F> 0 is predicted the absence of the risk of occurrence of adverse effects, and when F <0 - the risk of occurrence of adverse effects.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| MDS20100154A MD291Z (en) | 2010-07-19 | 2010-07-19 | Method for predicting the development of adverse effects in hearing aids |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| MDS20100154A MD291Z (en) | 2010-07-19 | 2010-07-19 | Method for predicting the development of adverse effects in hearing aids |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MD291Y true MD291Y (en) | 2010-11-30 |
| MD291Z MD291Z (en) | 2011-07-31 |
Family
ID=45815233
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MDS20100154A MD291Z (en) | 2010-07-19 | 2010-07-19 | Method for predicting the development of adverse effects in hearing aids |
Country Status (1)
| Country | Link |
|---|---|
| MD (1) | MD291Z (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MD732Z (en) * | 2013-04-12 | 2014-09-30 | Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова | Method for determining the maximum speech intelligibility index |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MD1039C2 (en) * | 1997-02-13 | 1999-06-30 | Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова | Diagnosis method of latent inflammatory affections of the midlle ear to children during their first year of life |
| MD1041C2 (en) * | 1997-02-13 | 1999-06-30 | Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова | Method for prognostication of middle ear latent diseases to children in the first year of life |
-
2010
- 2010-07-19 MD MDS20100154A patent/MD291Z/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| MD291Z (en) | 2011-07-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MY186986A (en) | Compositions and methods of use of phorbol esters | |
| IN2014DN10121A (en) | ||
| AR081166A1 (en) | ANGIOGENESIS FOR THE USE OF PLACENTARY MOTHER CELLS | |
| MX418589B (en) | Complement component c5 irna compositions and methods of use thereof | |
| DK2227257T3 (en) | DEVICES FOR MINIMUM-INVASIVE EXTRAOCULAR RADIATION TO THE POSTERIOR PART OF THE EYE | |
| EA201000897A1 (en) | COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS FOR REDUCING URIC ACID LEVEL | |
| DE602007013618D1 (en) | ANTIBODIES TO THE HUMAN CYTOMEGALIE VIRUS (HCMV) | |
| PH12013501773A1 (en) | Nutritional compositions for increasing arginine levels and methods of using same | |
| MA42016A1 (en) | Pharmaceutical compositions containing an integrin alpha 4 antagonist, used for the treatment of ocular inflammatory conditions | |
| Raghavan et al. | Immunogenetics of HIV and HIV associated tuberculosis | |
| CN204766041U (en) | Nose prosthesis with thickening layer | |
| MD291Y (en) | Method for predicting the development of adverse effects in hearing aids | |
| EP2826377A4 (en) | BONE MEASURING SYSTEM PRESENTED ON BONE FOR THE PREVIOUS MEMBER PART AND METHOD OF BONING | |
| EP2941437A4 (en) | PREPARATIONS OF HYDROPHOBIC THERAPEUTIC AGENTS, METHODS OF MAKING AND USING THEM | |
| CN104939871B (en) | A kind of prominent protection guide plate of ankylosis of temporo-mandibular joint osteotomy condyle | |
| RU2017110748A (en) | A method for assessing the severity of a patient's condition with HIV infection | |
| BR112018010516A2 (en) | oral care gel | |
| Zhang et al. | Long-term efficacy of triple semicircular canal occlusion in the treatment of intractable Meniere's disease | |
| 陳克耀 et al. | Serological survey of equine piroplasmosis, equine granulocytic anaplasmosis, and equine Lyme disease in Taiwan | |
| Polunina et al. | The risk of infection transfer during blood transfusion | |
| RU2700631C1 (en) | Method of estimating the area of eukaryotic cells adhered on opaque surfaces | |
| Yavasoglu et al. | Penile ulcer ATRA related in patient with acute promyelocytic leukemia | |
| Dumić-Čule et al. | Mini skull collection: recent measurements report | |
| Kochhar et al. | Embodiment of copper into dental armamentarium: A Hypotheses | |
| O'grady et al. | Rethinking mandatory HIV testing |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| KA4Y | Short-term patent lapsed due to non-payment of fees (with right of restoration) |